Insurance Claim Invalidated Due to Brain Hemorrhage – The Trap of Hospital Microscope Verification

A recent case has emerged where a man’s 40 million won insurance claim was invalidated after a microscope examination determined that a hemorrhage within a brain tumor was classified as a hemorrhage. This incident highlights the limitations of simple microscope verification and raises complex issues between medical diagnoses and insurance company judgments. Utilizing FireMarkets’ data analysis, we can track the frequency of similar cases and changes in insurance payout rates, further clarifying the severity of these challenges.

Background of the Case: Medical Judgment and Insurance Interpretation

The core of the case involved a man who filed an insurance claim of 40 million won after being diagnosed with a brain tumor. The insurance company classified the hemorrhage within the brain tumor as a hemorrhage and denied the insurance payout based on a microscope examination. This incident demonstrates the subtle differences between medical diagnoses and insurance company interpretations.

Limitations of Microscope Verification

Microscope verification is effective in confirming the presence of hemorrhage by observing the microscopic structure of brain tissue. However, it has limitations in accurately determining the cause, size, location, and impact of the hemorrhage on the brain tissue. In particular, hemorrhages within brain tumors can be very complex and subtle, making it difficult to make accurate judgments solely based on microscope verification.

Insurance Company’s Judgment Criteria

Insurance companies determine insurance payouts based on the terms of the insurance policy. Insurance policies typically include ‘hemorrhage’ as a covered event, but ‘hemorrhage within a brain tumor’ may not be explicitly included. Therefore, the insurance company assesses whether the symptoms are similar to ‘hemorrhage’ based on the microscope examination results to determine whether to pay out the insurance.

Legal Review and Future Outlook

This case requires legal review of the insurance policy terms and medical diagnoses. If the insurance policy does not have a clear definition of ‘hemorrhage within a brain tumor,’ the court will consider the general meaning of the insurance policy and the medical diagnosis in combination to determine whether to pay out the insurance. In future similar cases, it is expected that the court will take a more cautious approach to interpreting the insurance policy.